Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$541K Sell
5,071
-39,812
-89% -$4.82M 0.03% 435
2026
Q1
$7.34M Buy
44,883
+5,901
+15% +$907K 0.42% 58
2025
Q4
$6.23M Sell
38,982
-10,556
-21% -$1.93M 0.35% 69
2025
Q3
$8.32M Sell
49,538
-322
-0.6% -$39.4K 0.45% 44
2025
Q2
$5.35M Sell
49,860
-3,929
-7% -$300K 0.31% 77
2025
Q1
$4.1M Buy
53,789
+17,693
+49% +$1.35M 0.35% 64
2024
Q4
$2.49M Buy
+36,096
New +$2.6M 0.15% 143

Other funds holding INSM

NWAM LLC's INSM Position: Q2 2026 in Review

NWAM LLC reduced its Insmed (INSM) stake by 89% in Q2 2026, selling an estimated $4.82M and leaving 5,071 shares worth $541K. The position accounts for 0.03% of the portfolio, ranked #435.

NWAM LLC first reported a position in INSM in Q4 2024 and has held it in 7 quarters since. The position peaked at $8.32M in Q3 2025. 665 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • NWAM LLC held 5,071 shares of Insmed worth $541K as of Q2 2026.
  • NWAM LLC sold 39,812 Insmed shares in Q2 2026, an estimated $4.82M.
  • Insmed made up 0.03% of NWAM LLC's portfolio in Q2 2026, its #435 holding.
  • NWAM LLC first reported a position in Insmed in Q4 2024 and has held it in 7 quarters since.
  • NWAM LLC's Insmed position peaked at $8.32M in Q3 2025.
  • 665 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on NWAM LLC's 13F filing for Q2 2026, filed 23 Jul 2026.